Bradley van Paridon
By
Bradley van Paridon
Published: July 12, 2022, 8:37 p.m.·
Tags:
Diagnostics
The use of nanopore sequencing for the early identification of pulmonary tuberculosis (TB) infection had superior diagnostic accuracy compared with both Mycobacterium tuberculosis (MTB) culture analyses and Xpert MTB/rifampin (RIF) assays, according to results of a study published in International Journal of Infectious Diseases.
Read More →
By
Bradley van Paridon
Published: Feb. 11, 2022, 9:05 p.m.·
Tags:
Treatment
Treatment with high-dose rifamycin (HDR)-based regimens was not associated with an increased risk for severe adverse events (SAE) compared with standard-dose rifamycin (SDR)-based regimens among patients with tuberculosis (TB) infection, according to results of a study published in Thorax.
Read More →
By
Bradley van Paridon
Published: Jan. 19, 2022, 9:05 p.m.·
Tags:
Diagnostics,
TB care
A multicomponent diagnostic strategy was found to increase the number of patients being tested, diagnosed, and treated for confirmed tuberculosis (TB) infection, according to results of a cluster-randomized study published in The New England Journal of Medicine.
Read More →
By
Bradley van Paridon
Published: May 6, 2021, 12:20 a.m.·
Tags:
Treatment
An RNA signature of tuberculosis, RISK11, was used to discriminate between individuals with prevalent tuberculosis or progression to incident tuberculosis and individuals who remained healthy, according to a study in The Lancet Infectious Diseases.
Read More →
By
Bradley van Paridon
Published: Oct. 30, 2020, 2:35 p.m.·
Tags:
Pediatrics
Among a cohort of children living in contact with sputum smear-positive adult tuberculosis (TB) patients on Directly Observed Treatment Short Course (DOTS), roughly half the children were suffering from tuberculosis or tubercular infection, according to a follow-up study published in BMC Infectious Diseases.
Read More →
By
Bradley van Paridon
Published: March 25, 2020, midnight·
Tags:
HIV coinfection,
Scientific research
Active infection with Mycobacterium tuberculosis (TB) enhances anti-HIV-1 antibody response, which may then lead to the emergence of broadly neutralizing antibodies (bnAbs) that target conserved envelope domains.
Read More →
By
Bradley van Paridon
Published: Oct. 14, 2019, 2:04 p.m.·
Tags:
HIV coinfection,
Pediatrics,
Treatment
A new treatment-decision score for the diagnosis of tuberculosis (TB) in children with HIV performed well, and when used in an algorithm may facilitate prompt treatment decision making for children at a high risk for mortality, according to data published in Pediatrics.
Read More →
By
Bradley van Paridon
Published: April 14, 2019, 9:49 p.m.·
Tags:
Pediatrics,
Drug-resistant TB,
Treatment
According to data published in Antimicrobial Agents and Chemotherapy, the dosing recommendations regarding levofloxacin for the treatment and prevention of drug-resistant tuberculosis (DR-TB) in children may need to be re-evaluated.
Read More →
By
Bradley van Paridon
Published: Jan. 9, 2019, 9:27 p.m.·
Tags:
Diagnostics
A deep-learning algorithm performed better than radiologists at detecting active pulmonary tuberculosis (TB) on chest radiographs, according to data published in Clinical Infectious Diseases.
Read More →
By
Bradley van Paridon
Published: March 10, 2018, 6:23 p.m.·
Tags:
Treatment
Shorter treatment regimens for tuberculosis (TB) were associated with increased completion rates and fewer adverse events compared with traditional regimens, according to a study published in Pediatrics.
Read More →
Page 1 of 1 · Total posts: 10
1